RxDoctor Payments Data

Qasim Alkhafaf, MD

Psychiatry · Southfield, MINPI 1861951014

Payments from drug & device makers

$2,008in general payments, 2019–2025

Across 117 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$334
  • AbbVie$319
  • Johnson & Johnson$246
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$212
  • Teva Pharmaceuticals USA, Inc.$189
  • Alkermes, Inc.$187
  • plus $521 from 6 others

What the payments were for

  • Food & beverage$1,98099%
  • Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,008 in reported general payments places this provider in the 85th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$20,031
Medicare patients
45
Services billed
238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl56$86,963
Invega SustennaPaliperidone Palmitate20$68,919
AristadaAripiprazole Lauroxil18$57,138
CaplytaLumateperone Tosylate16$35,545
Abilify MaintenaAripiprazole12$33,787
Aripiprazole94$3,194
Paliperidone ErPaliperidone22$2,737
Oxcarbazepine21$2,392
Fluphenazine Decanoate20$1,813
Clozapine40$1,721
Risperidone110$1,438
Fluphenazine Hcl17$1,344
Quetiapine Fumarate113$1,296
Lurasidone Hcl27$1,074
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine14$1,031

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$319$86,96356 claims
Johnson & JohnsonInvega Sustenna$246$68,91920 claims
Alkermes, Inc.Aristada$187$57,13818 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$212$35,54516 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$334$33,78712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Southfield

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →